<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124391">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01924273</url>
  </required_header>
  <id_info>
    <org_study_id>HD065536</org_study_id>
    <nct_id>NCT01924273</nct_id>
  </id_info>
  <brief_title>Novel Treatment for Port Wine Stain Birthmarks</brief_title>
  <official_title>Novel Treatment for Port Wine Stain Birthmarks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montana Compton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Port wine stains are congenital, progressive vascular malformations of the skin that occur
      in approximately 0.7% of newborns. Port wine stains are initially flat and red, but with
      time, they tend to darken to purple and become thickened as vascular nodules develop.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Researchers at Beckman Laser Institute develop a better treatment that can use Photodynamic
      therapy which involves light activation because the photosensitizer can be localized to a
      desired portion of the Port wine stains, Pulsed dye laser creates an opportunity for
      targeted destruction of Port wine stains. The researcher wants to use Photodynamic therapy
      with in conjunction with Pulsed dye laser
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Port wine stains</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Port-Wine Stain</condition>
  <arm_group>
    <arm_group_label>Talaporfin sodium</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Talaporfin sodium</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Talaporfin sodium</intervention_name>
    <description>Talaporfin sodium</description>
    <arm_group_label>Talaporfin sodium</arm_group_label>
    <other_name>Talaporfin sodium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male/Female 18 years and older

          -  Have Port Wine Stain Birthmarks non-facial

        Exclusion Criteria:

          -  Under 18 years of age

          -  No Port Wine Stain Birthmarks

          -  pregnant/breast feeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Kelly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Montana Compton, RN</last_name>
    <phone>949.824.9265</phone>
    <email>mocomton@uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beckman Laser Institute</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Montana Compton, RN</last_name>
      <phone>949-824-9265</phone>
      <email>mocomton@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Montana Compton, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard Choi, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wesley Moy, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruce Yang, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shaadi Khademi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Montana Compton</investigator_full_name>
    <investigator_title>Research Nurse</investigator_title>
  </responsible_party>
  <keyword>Port Wine Stain Birthmarks</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Port-Wine Stain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Talaporfin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
